Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
FDA Approves Bausch Health's DUOBRII™ (Halobetasol Propionate And Tazarotene) Lotion 0.01%/0.045% For Plaque Psoriasis In Adults
LAVAL, Quebec, April 25, 2019 /PRNewswire/ -- Bausch Health Companies Inc.
Pharma and healthcare's digital ad spend to reach $10B next year: report
Digital advertising is booming in pharma and healthcare, and it's expected to rise to $10 billion in 2020.
New plant to make Merck KGaA drugs opens in Iran
Iran is one of those tricky markets, even for European companies, as the U.
Glaxo To Invest USD100 Million In US Vaccine Manufacturing Site
LONDON (Alliance News) - GlaxoSmithKline PLC said on Wednesday it will invest USD100 million in its manufacturing site in Montana, US, to expand long-term vaccine manufacturing capabilities.
Bayer says it is looking into established drugs strategy
FRANKFURT (Reuters) - Bayer is looking into future options for its established drugs business, partly because of price pressure in China, the German company’s head of pharmaceuticals said on...
AbbVie's Skyrizi drug to treat psoriasis wins U.S. approval
(Reuters) - AbbVie Inc said on Tuesday that the U.
Autolus Therapeutics Receives FDA Orphan Drug Designation for AUTO3 for Treatment of Acute Lymphoblastic Leukemia
LONDON, April 23, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq.
Gilead Announces Topline Data From Phase 3 STELLAR-3 Study of Selonsertib in Bridging Fibrosis (F3) Due to Nonalcoholic Steatohepatitis (NASH)
FOSTER CITY, Calif.
Researchers use machine-learning system to diagnose genetic diseases
Researchers at Rady Children's Institute for Genomic Medicine (RCIGM) have utilized a machine-learning process and clinical natural language processing (CNLP) to diagnose rare gene...
Lilly Announces Positive Top-Line Results for COAST-X, a 52-Week Placebo-Controlled Study of Taltz® (ixekizumab) in Patients with Non-Radiographic Axial Spondyloarthritis
INDIANAPOLIS, April 22, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE.
New nanomedicine slips through the cracks
In a recent study in mice, researchers found a way to deliver specific drugs to parts of the body that are exceptionally difficult to access.
Massive roll out of world’s first malaria vaccine commences in Africa
After decades of development and testing the world's first malaria vaccine is beginning a wide roll out, commencing in Malawi before being introduced into Ghana and Kenya over the following weeks.
410
411
412
413
414
415
416
417
418
